XML 112 R47.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of operating results by reportable segment
The summarized operating results of the Company's reportable segments are as follows:
Year Ended December 31, 2024
UraniumHeavy Mineral SandsRare Earth Elements
Unallocated(1)
Consolidated Total
Revenues$38,240 $39,874 $— $— $78,114 
Operating costs and expenses:
Costs applicable to revenues16,580 39,338 — — 55,918 
Exploration, development and processing(2)
7,232 2,628 4,319 — 14,179 
Standby(2)
6,520 — — — 6,520 
Accretion of asset retirement obligations1,253 815 — — 2,068 
Selling, general and administrative (excluding share-based compensation)12,733 10,995 7,459 — 31,187 
Share-based compensation2,660 1,196 1,558 — 5,414 
Transactions and integration related costs— — — 10,343 10,343 
Total operating costs and expenses46,978 54,972 13,336 10,343 125,629 
Operating loss$(8,738)$(15,098)$(13,336)$(10,343)$(47,515)
(1) Corporate expenses that are not directly attributable to the uranium, heavy mineral sands or rare earth elements segments and are evaluated on a consolidated basis.
(2)    Includes depreciation, depletion and amortization expense of $1.07 million, $1.85 million and $0.21 million related to the uranium, HMS and REE segments, respectively. Depreciation, depletion and amortization expense is included in the Exploration, development and processing and standby expense financial statement line items on the consolidated statement of operations and comprehensive income (loss).
Year Ended December 31, 2023
UraniumHeavy Mineral SandsRare Earth Elements
Unallocated(1)
Consolidated Total
Revenues$35,080 $— $2,848 $— $37,928 
Operating costs and expenses:
Costs applicable to revenues15,869 — 2,312 — 18,181 
Exploration, development and processing(2)
5,584 583 9,364 — 15,531 
Standby(2)
7,476 — — — 7,476 
Accretion of asset retirement obligations1,192 — — — 1,192 
Selling, general and administrative (excluding share-based compensation)12,899 2,590 7,801 — 23,290 
Share-based compensation2,562 514 1,549 — 4,625 
Total operating costs and expenses45,582 3,687 21,026 — 70,295 
Operating loss$(10,502)$(3,687)$(18,178)$— $(32,367)
(1) Corporate expenses that are not directly attributable to the uranium, heavy mineral sands or rare earth elements segments and are evaluated on a consolidated basis.
(2)    Includes depreciation, depletion and amortization expense of $1.95 million, $0.58 million and $0.22 million related to the uranium, HMS and REE segments, respectively. Depreciation, depletion and amortization expense is included in the Exploration, development and processing and standby expense financial statement line items on the consolidated statement of operations and comprehensive income (loss).
Year Ended December 31, 2022
UraniumHeavy Mineral SandsRare Earth Elements
Unallocated(1)
Consolidated Total
Revenues$10,393 $— $2,122 $— $12,515 
Operating costs and expenses:
Costs applicable to revenues3,769 — 4,075 — 7,844 
Exploration, development and processing(2)
6,543 — 2,803 — 9,346 
Standby(2)
13,221 — — — 13,221 
Accretion of asset retirement obligations1,556 — — — 1,556 
Selling, general and administrative (excluding share-based compensation)11,966 540 8,339 — 20,845 
Share-based compensation2,664 120 1,857 — 4,641 
Total operating costs and expenses39,719 660 17,074 — 57,453 
Operating loss$(29,326)$(660)$(14,952)$— $(44,938)
(1) Corporate expenses that are not directly attributable to the uranium, heavy mineral sands or rare earth elements segments and are evaluated on a consolidated basis.
(2)    Includes depreciation, depletion and amortization expense of $3.27 million related to the uranium segment. Depreciation, depletion and amortization expense is included in the Exploration, development and processing and standby expense financial statement line items on the consolidated statement of operations and comprehensive income (loss). No depreciation, depletion and amortization expense was recorded related to the HMS and REE segments.